A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function
The DOI matches its Crossref record; 245 of the 249 references it cites were found in a registry or an index.
Abstract
Up to 15% of patients with essential hypertension have inappropriate regulation of aldosterone; although only a minority have distinct adrenal tumors, recent evidence shows that mineralocorticoid receptor activation contributes to the age-related blood pressure rise and illustrates the importance of aldosterone in determining cardiovascular risk. Aldosterone also has a major role in progression and outcome of ischemic heart disease. These data highlight the need to understand better the regulation of aldosterone synthesis and its action. Aldosterone effects are mediated mainly through classical nuclear receptors that alter gene transcription. In classic epithelial target tissues, signaling mechanisms are relatively well defined. However, aldosterone has major effects in nonepithelial tissues that include increased synthesis of proinflammatory molecules and reactive oxygen species; it remains unclear how these effects are controlled and how receptor specificity is maintained. Variation in aldosterone production reflects interaction of genetic and environmental factors. Although the environmental factors are well understood, the genetic control of aldosterone synthesis is still the subject of debate. Aldosterone synthase (encoded by the CYP11B2 gene) controls conversion of deoxycorticosterone to aldosterone. Polymorphic variation in CYP11B2 is associated with increased risk of hypertension, but the molecular mechanism that accounts for this is not known. Altered 11beta-hydroxylase efficiency (conversion of deoxycortisol to cortisol) as a consequence of variation in the neighboring gene (CYP11B1) may be important in contributing to altered control of aldosterone synthesis, so that the risk of hypertension may reflect a digenic effect, a concept that is discussed further. There is evidence that a long-term increase in aldosterone production from early life is determined by an interaction of genetic and environmental factors, leading to the eventual phenotypes of aldosterone-associated hypertension and cardiovascular damage in middle age and beyond. The importance of aldosterone has generated interest in its therapeutic modulation. Disadvantages associated with spironolactone (altered libido, gynecomastia) have led to a search for alternative mineralocorticoid receptor antagonists. Of these, eplerenone has been shown to reduce cardiovascular risk after myocardial infarction. The benefits and disadvantages of this therapeutic approach are discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism (PA) is associated with increased risk for dysglycemia.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [7]
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., Perry, J. R. B., Elliott, K. S., Lango, H., Rayner, N. W., et al. (2007) · Science · doi:10.1126/science.1141634 · Cited by 4,531
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones
Payne, A. H., & Hales, D. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0030 · Cited by 1,766
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040135 · Cited by 1,761
The cloning of a family of genes that encode the melanocortin receptors
Mountjoy, K. G., Robbins, L. S., Mortrud, M. T., & Cone, R. D. (1992) · Science · doi:10.1126/science.1325670 · Cited by 1,635
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X., Plouin, P.-F., Blacher, J., Safar, M. E., & Mourad, J.-J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,547
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis
Lin, D., Sugawara, T., Strauss, J. F., Clark, B. J., Stocco, D. M., Saenger, P., Rogol, A., & Miller, W. L. (1995) · Science · doi:10.1126/science.7892608 · Cited by 1,030
Mulatero (2004) · doi:10.1210/jc.2003-031337 · Cited by 961
Zannad, F., Alla, F., Dousset, B., Perez, A., & Pitt, B. (2000) · Circulation · doi:10.1161/01.cir.102.22.2700 · Cited by 947
StAR protein and the regulation of steroid hormone biosynthesis.
Stocco, D. M. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.193 · Cited by 917
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension
Calhoun, D. A., Nishizaka, M. K., Zaman, M. A., Thakkar, R. B., & Weissmann, P. (2002) · Hypertension · doi:10.1161/01.hyp.0000040261.30455.b6 · Cited by 763
Pitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
McKelvie, R. S., Yusuf, S., Pericak, D., Avezum, A., Burns, R. J., Probstfield, J., Tsuyuki, R. T., White, M., Rouleau, J., Latini, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.10.1056 · Cited by 692
Primary aldosteronism: renaissance of a syndrome
Young, W. F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02775.x · Cited by 680
Remodeling of the rat right and left ventricles in experimental hypertension.
Brilla, C. G., Pick, R., Tan, L. B., Janicki, J. S., & Weber, K. T. (1990) · Circulation Research · doi:10.1161/01.res.67.6.1355 · Cited by 674
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 655
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
Chapman, N., Dobson, J., Wilson, S., Dahlöf, B., Sever, P. S., Wedel, H., & Poulter, N. R. (2007) · Hypertension · doi:10.1161/01.hyp.0000259805.18468.8c · Cited by 629
Pitt, B., Reichek, N., Willenbrock, R., Zannad, F., Phillips, R. A., Roniker, B., Kleiman, J., Krause, S., Burns, D., & Williams, G. H. (2003) · Circulation · doi:10.1161/01.cir.0000091405.00772.6e · Cited by 623
Minireview: Overview of the Renin-Angiotensin System—An Endocrine and Paracrine System
Lavoie, J. L., & Sigmund, C. D. (2003) · Endocrinology · doi:10.1210/en.2003-0150 · Cited by 576
Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 571
Structure of human steroid 21-hydroxylase genes.
White, P. C., New, M. I., & Dupont, B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5111 · Cited by 569
Aldosterone-Induced Inflammation in the Rat Heart
Sun, Y., Zhang, J., Lu, L., Chen, S. S., Quinn, M. T., & Weber, K. T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64454-9 · Cited by 567
Sutherland, D. J., Ruse, J. L., & Laidlaw, J. C. (1966) · PubMed · Cited by 542
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
Blasi, E. R., Rocha, R., Rudolph, A. E., Blomme, E. A. G., Polly, M. L., & McMahon, E. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00929.x · Cited by 542
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505
Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Khanna, K., Zuckerman, A., & Stier, C. T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.451 · Cited by 496
Control of aldosterone secretion: a model for convergence in cellular signaling pathways
SPÄT, A., & HUNYADY, L. (2004) · Physiological Reviews · doi:10.1152/physrev.00030.2003 · Cited by 494
Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
Rocha, R. (2000) · Endocrinology · doi:10.1210/en.141.10.3871 · Cited by 475
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Epstein, M., Williams, G. H., Weinberger, M., Lewin, A., Krause, S., Mukherjee, R., Patni, R., & Beckerman, B. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240106 · Cited by 459
Myocardial Production of Aldosterone and Corticosterone in the Rat
Silvestre, J.-S., Robert, V., Heymes, C., Aupetit-Faisant, B., Mouas, C., Moalic, J.-M., Swynghedauw, B., & Delcayre, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4883 · Cited by 446
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).
Mornet, É., Dupont, J., Vitek, A., & White, P. C. (1989) · PubMed · Cited by 440
Effect of aging on plasma renin and aldosterone in normal man
Weidmann, P., De Myttenaere-Bursztein, S., Maxwell, M. H., & de Lima, J. (1975) · Kidney International · doi:10.1038/ki.1975.120 · Cited by 440
Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart, P. M., Corrie, J. E., Shackleton, C. H., & Edwards, C. R. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113592 · Cited by 430
Brilla, C. G., Matsubara, L. S., & Weber, K. T. (1993) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1993.1066 · Cited by 425
Mineralocorticoid receptor knockout mice: Pathophysiology of Na + metabolism
Berger, S., Bleich, M., Schmid, W., Cole, T. J., Peters, J., Watanabe, H., Kriz, W., Warth, R., Greger, R., & Schütz, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9424 · Cited by 418
Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β)
Mornet, E., Dupont, J., Vitek, A., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30030-4 · Cited by 405
Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain
Mellon, S. H., & Deschepper, C. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91332-m · Cited by 398
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension
Weinberger, M. H., Roniker, B., Krause, S. L., & Weiss, R. J. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02957-6 · Cited by 388
Snyder, P. M., Olson, D. R., & Thomas, B. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100623200 · Cited by 381
Minireview: Primary Aldosteronism—Changing Concepts in Diagnosis and Treatment
Young, W. F. (2003) · Endocrinology · doi:10.1210/en.2003-0279 · Cited by 376
Cardiovascular and humoral responses to extremes of sodium intake in normal black and white men.
Luft, F. C., Rankin, L. I., Bloch, R., Weyman, A. E., Willis, L. R., Murray, R. H., Grim, C. E., & Weinberger, M. H. (1979) · Circulation · doi:10.1161/01.cir.60.3.697 · Cited by 361
Aldosterone Production Is Activated in Failing Ventricle in Humans
Mizuno, Y., Yoshimura, M., Yasue, H., Sakamoto, T., Ogawa, H., Kugiyama, K., Harada, E., Nakayama, M., Nakamura, S., Ito, T., et al. (2001) · Circulation · doi:10.1161/01.cir.103.1.72 · Cited by 345
Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J., Shah, A. M., Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J., & Shah, A. M. (2006) · The FASEB Journal · doi:10.1096/fj.05-4642fje · Cited by 318
Regulation of Aldosterone Secretion
Quinn, S. J., & Williams, G. H. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002205 · Cited by 313
Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Zuckerman, A., & Stier, C. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.232 · Cited by 310
Broadwell, R. D., & Sofroniew, M. V. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1059 · Cited by 309
White, W. B., Duprez, D., St Hillaire, R., Krause, S., Roniker, B., Kuse-Hamilton, J., & Weber, M. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000067463.13172.ea · Cited by 295
Oh, B.-H., Mitchell, J., Herron, J. R., Chung, J., Khan, M., & Keefe, D. L. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.032 · Cited by 276
Disorders of Steroid 11β-Hydroxylase Isozymes*
WHITE, P. C., CURNOW, K. M., & PASCOE, L. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-4-421 · Cited by 271
Transgenic Model of Aldosterone-Driven Cardiac Hypertrophy and Heart Failure
Qin, W., Rudolph, A. E., Bond, B. R., Rocha, R., Blomme, E. A. G., Goellner, J. J., Funder, J. W., & McMahon, E. G. (2003) · Circulation Research · doi:10.1161/01.res.0000080521.15238.e5 · Cited by 262
Dzau, V. J., Bernstein, K., Celermajer, D., Cohen, J., Dahlöf, B., Deanfield, J., Diez, J., Drexler, H., Ferrari, R., van Gilst, W., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01878-1 · Cited by 259
PRIMARY ALDOSTERONISM, A NEW CLINICAL ENTITY
CONN, J. W., & LOUIS, L. H. (1956) · Annals of Internal Medicine · doi:10.7326/0003-4819-44-1-1 · Cited by 255
Davies, E., Holloway, C. D., Ingram, M. C., Inglis, G. C., Friel, E. C., Morrison, C., Anderson, N. H., Fraser, R., & Connell, J. M. C. (1999) · Hypertension · doi:10.1161/01.hyp.33.2.703 · Cited by 240
Self-citationFurukawa, A., Miyatake, A., Ohnishi, T., & Ichikawa, Y. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062231.x · Cited by 231
Structural Analysis and Evaluation of the Aldosterone Synthase Gene in Hypertension
Brand, E., Chatelain, N., Mulatero, P., Féry, I., Curnow, K., Jeunemaitre, X., Corvol, P., Pascoe, L., & Soubrier, F. (1998) · Hypertension · doi:10.1161/01.hyp.32.2.198 · Cited by 229
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients
Flack, J. M., Oparil, S., Pratt, J. H., Roniker, B., Garthwaite, S., Kleiman, J. H., Yang, Y., Krause, S. L., Workman, D., & Saunders, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00054-8 · Cited by 224
The regulation of aldosterone synthase expression
Bassett, M. H., White, P. C., & Rainey, W. E. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.011 · Cited by 220
Newton-Cheh, C., Guo, C.-Y., Gona, P., Larson, M. G., Benjamin, E. J., Wang, T. J., Kathiresan, S., O’Donnell, C. J., Musone, S. L., Camargo, A. L., et al. (2007) · Hypertension · doi:10.1161/01.hyp.0000258554.87444.91 · Cited by 218
Fiebeler, A., Schmidt, F., Müller, D. N., Park, J.-K., Dechend, R., Bieringer, M., Shagdarsuren, E., Breu, V., Haller, H., & Luft, F. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.787 · Cited by 213
Pathophysiological effects of aldosterone in cardiovascular tissues
Rocha, R., & Stier, C. T. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00432-5 · Cited by 212
11β-Hydroxysteroid Dehydrogenase in the Brain: A Novel Regulator of Glucocorticoid Action?
Seckl, J. R. (1997) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1996.0143 · Cited by 212
Diurnal Variation of Plasma Aldosterone, Cortisol and Renin Activity in Supine Man
KATZ, F. H., ROMFH, P., SMITH, J. A., ROPER, E. F., BARNES, J. S., & BOYD, J. B. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-1-125 · Cited by 208
Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11).
Chua, S. C., Szabo, P., Vitek, A., Grzeschik, K. H., John, M., & White, P. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7193 · Cited by 206
Konstitution des Aldosterons, des neuen Mineralocorticoids
Simpson, S. A., Tait, J. F., Wettstein, A., Neher, R., v. Euw, J., Schindler, O., & Reichstein, T. (1954) · Experientia · doi:10.1007/bf02158515 · Cited by 206
Genotype-Phenotype Relationships for the Renin-Angiotensin-Aldosterone System in a Normal Population
Paillard, F., Chansel, D., Brand, E., Benetos, A., Thomas, F., Czekalski, S., Ardaillou, R., & Soubrier, F. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.423 · Cited by 206
Chappell, M. C. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.076216 · Cited by 206
Montori, V. M., & Young, W. F. (2002) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00013-0 · Cited by 202
Angiotensin II and Potassium Regulate Human CYP11B2 Transcription through Common cis-Elements
Clyne, C. D., Zhang, Y., Slutsker, L., Mathis, J. M., White, P. C., & Rainey, W. E. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.5.9920 · Cited by 202
Intracranial Aneurysm and Hemorrhagic Stroke in Glucocorticoid-remediable Aldosteronism
Litchfield, W. R., Anderson, B. F., Weiss, R. J., Lifton, R. P., & Dluhy, R. G. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.445 · Cited by 198
VELDHUIS, J. D., IRANMANESH, A., JOHNSON, M. L., & LIZARRALDE, G. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1616 · Cited by 194
Steroidogenic electron transport in adrenal cortex mitochondria
Lambeth, J. D., Seybert, D. W., Lancaster, J. R., Salerno, J. C., & Kamin, H. (1982) · Molecular and Cellular Biochemistry · doi:10.1007/bf01283159 · Cited by 192
White, P. C., & Slutsker, L. (1995) · Endocrine Research · doi:10.3109/07435809509030459 · Cited by 190
Beygui, F., Collet, J.-P., Benoliel, J.-J., Vignolles, N., Dumaine, R., Barthélémy, O., & Montalescot, G. (2006) · Circulation · doi:10.1161/circulationaha.106.634626 · Cited by 190
Connell, J. M. C., Whitworth, J. A., Davies, D. L., Lever, A. F., Richards, A. M., & Fraser, R. (1987) · Journal of Hypertension · doi:10.1097/00004872-198708000-00007 · Cited by 188
Self-citationStockand, J. D., & Meszaros, J. G. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00421.2002 · Cited by 187
Rich, G. M., Ulick, S., Cook, S., Wang, J. Z., Lifton, R. P., & Dluhy, R. G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-10-813 · Cited by 186
Zhang, W., Xia, X., Reisenauer, M. R., Rieg, T., Lang, F., Kuhl, D., Vallon, V., & Kone, B. C. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29850 · Cited by 180
Diakov, A., & Korbmacher, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403260200 · Cited by 180
Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.
Robert, V, Van Thiem, N., Cheav, S. L., Mouas, C., Swynghedauw, B., & Delcayre, C. (1994) · Hypertension · doi:10.1161/01.hyp.24.1.30 · Cited by 180
Sala, G. B., Hayashi, K., Catt, K. J., & Dufau, M. L. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50666-9 · Cited by 177
Weidmann, P., Beretta-Piccoli, C., Ziegler, W. H., Keusch, G., Glück, Z., & Reubi, F. C. (1978) · Kidney International · doi:10.1038/ki.1978.171 · Cited by 176
Intracerebroventricular Infusion of Aldosterone Induces Hypertension in Rats*
GOMEZ-SANCHEZ, E. P. (1986) · Endocrinology · doi:10.1210/endo-118-2-819 · Cited by 176
Genetic Determination of Plasma Aldosterone Levels in Essential Hypertension
Pojoga, L., Gautier, S., Blanc, H., Guyene, T.-T., Poirier, O., Cambien, F., & Benetos, A. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00048-x · Cited by 176
Hormonal regulation of ENaCs: insulin and aldosterone
Blazer-Yost, B. L., Liu, X., & Helman, S. I. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.5.c1373 · Cited by 175
Steroidogenic enzyme gene expression in the human heart
Kayes-Wandover, K. M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.7.2519 · Cited by 174
Guo, C., Martinez-Vasquez, D., Mendez, G. P., Toniolo, M. F., Yao, T. M., Oestreicher, E. M., Kikuchi, T., Lapointe, N., Pojoga, L., Williams, G. H., et al. (2006) · Endocrinology · doi:10.1210/en.2006-0944 · Cited by 173
Takeda, Y. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2797 · Cited by 169
Luther, J. M., Gainer, J. V., Murphey, L. J., Yu, C., Vaughan, D. E., Morrow, J. D., & Brown, N. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000248135.97380.76 · Cited by 169
Production of Aldosterone in Isolated Rat Blood Vessels
Takeda, Y., Miyamori, I., Yoneda, T., Iki, K., Hatakeyama, H., Blair, I. A., Hsieh, F.-Y., & Takeda, R. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.170 · Cited by 168
Regulation of Aldosterone Biosynthesis
Müller, J. (1988) · Monographs on Endocrinology · doi:10.1007/978-3-642-83120-1 · Cited by 167
Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension
Williams, G. H., Burgess, E., Kolloch, R. E., Ruilope, L. M., Niegowska, J., Kipnes, M. S., Roniker, B., Patrick, J. L., & Krause, S. L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.01.007 · Cited by 166
SGK1 Regulation of Epithelial Sodium Transport
Pearce, D. (2003) · Cellular Physiology and Biochemistry · doi:10.1159/000070245 · Cited by 166
ACE2: A New Target for Cardiovascular Disease Therapeutics
Raizada, M. K., & Ferreira, A. J. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3180986219 · Cited by 166
Messenger RNAs encoding steroidogenic enzymes are expressed in rodent brain
Strömstedt, M., & Waterman, M. R. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00140-n · Cited by 164
New ideas about aldosterone signaling in epithelia
Stockand, J. D. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00320.2001 · Cited by 160
Kang, Y.-M., Zhang, Z.-H., Johnson, R. F., Yu, Y., Beltz, T., Johnson, A. K., Weiss, R. M., & Felder, R. B. (2006) · Circulation Research · doi:10.1161/01.res.0000244092.95152.86 · Cited by 157
Nagase, M., Matsui, H., Shibata, S., Gotoda, T., & Fujita, T. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091058 · Cited by 157
Profiling transcript levels for steroidogenic enzymes in fetal tissues
Pezzi, V., Mathis, J. M., Rainey, W. E., & Carr, B. R. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.07.006 · Cited by 156
Szasz, T. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91564-4 · Cited by 155
Colussi, G., Catena, C., Lapenna, R., Nadalini, E., Chiuch, A., & Sechi, L. A. (2007) · Diabetes Care · doi:10.2337/dc07-0525 · Cited by 155
Aldosterone to Renin Ratio in a Primary Care Setting: The Bussolengo Study
Olivieri, O., Ciacciarelli, A., Signorelli, D., Pizzolo, F., Guarini, P., Pavan, C., Corgnati, A., Falcone, S., Corrocher, R., Micchi, A., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032179 · Cited by 155
Funder, J. (1996) · Endocrinology · doi:10.1210/en.137.12.5264 · Cited by 154
Steroidogenic enzyme gene expression in the human brain
Yu, L., Romero, D. G., Gómez-Sánchez, C. E., & Gómez-Sánchez, E. P. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00041-2 · Cited by 154
Steroidogenic Enzyme Gene Expression in the Human Heart1
Kayes-Wandover, K. M., & White, P. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6663 · Cited by 154
Cardiac Aldosterone Production in Genetically Hypertensive Rats
Takeda, Y., Yoneda, T., Demura, M., Miyamori, I., & Mabuchi, H. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.495 · Cited by 151
Bassett, M., Zhang, Y., Clyne, C., White, P., & Rainey, W. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280125 · Cited by 146
TZUNODA, K., ABE, K., GOTO, T., YASUJIMA, M., SATO, M., OMATA, K., SEINO, M., & YOSHINAGA, K. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-62-2-384 · Cited by 146
Cicila, G. T., Rapp, J. P., Wang, J.-M., Lezin, E. S., Ng, S. C., & Kurtz, T. W. (1993) · Nature Genetics · doi:10.1038/ng0493-346 · Cited by 145
Aldosterone-sensitive neurons in the rat central nervous system
Geerling, J. C., Kawata, M., & Loewy, A. D. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20808 · Cited by 145
Macdonald, J. E., Kennedy, N., & Struthers, A. D. (2004) · Heart · doi:10.1136/hrt.2003.017368 · Cited by 141
Borghi, C., Boschi, S., Ambrosioni, E., Melandri, G., Branzi, A., & Magnani, B. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03901.x · Cited by 141
Aldosterone synthase deficiency and related disorders
White, P. C. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.013 · Cited by 140
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1998) · Endocrine Research · doi:10.3109/07435809809032689 · Cited by 139
Duprez, D. A., Bauwens, F. R., De Buyzere, M. L., De Backer, T. L., Kaufman, J. M., Van Hoecke, J., Vermeulen, A., & Clement, D. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90240-d · Cited by 139
Aldosterone, mineralocorticoid receptors and vascular inflammation
Funder, J. W. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.054 · Cited by 138
Origin of Aldosterone in the Rat Heart
Gomez-Sanchez, E. P., Ahmad, N., Romero, D. G., & Gomez-Sanchez, C. E. (2004) · Endocrinology · doi:10.1210/en.2004-0295 · Cited by 135
Extra‐adrenal production of corticosteroids
Davies, E., & MacKenzie, S. M. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03867.x · Cited by 134
Self-citationCardiac Steroidogenesis in the Normal and Failing Heart
Young, M. J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5121 · Cited by 134
LACHANCE, Y., LUU-THE, V., VERREAULT, H., DUMONT, M., RHÉAUME, E., LEBLANC, G., & LABRIE, F. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.701 · Cited by 129
11β-Hydroxysteroid dehydrogenase type 2 in the postnatal and adult rat brain
Robson, A. C., Leckie, C. M., Seckl, J. R., & Holmes, M. C. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00161-2 · Cited by 128
Phosphoinositide 3-kinase is required for aldosterone-regulated sodium reabsorption
Blazer-Yost, B. L., Păunescu, T. G., Helman, S. I., Lee, K. D., & Vlahos, C. J. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.3.c531 · Cited by 128
Diurnal Patterns of Blood Pressure, Heart Rate and Vasoactive Hormones in Normal Man
Richards, A. M., Nicholls, M. G., Espiner, E. A., Ikram, H., Cullens, M., & Hinton, D. (1986) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968609074769 · Cited by 117
Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension
Gomez-Sanchez, E. P., Fort, C. M., & Gomez-Sanchez, C. E. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.3.e482 · Cited by 116
Circadian Rhythm and Effect of Posture on Plasma Aldosterone Concentration in Primary Aldosteronism
Schambelan, M., Brust, N., CHANG, B. C. F., Slater, K. L., & Biglieri, E. G. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-43-1-115 · Cited by 116
Effects of eplerenone versus losartan in patients with low-renin hypertension
Weinberger, M. H., White, W. B., Ruilope, L. M., MacDonald, T. M., Davidson, R. C., Roniker, B., Patrick, J. L., & Krause, S. L. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.12.005 · Cited by 115
Swedberg, K. B., Eneroth, P. H. E., KJEKSHUS, J. K., & Snapinn, S. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90475-g · Cited by 114
IN VIVO AND IN VITRO STUDIES OF ADRENAL SECRETIONS IN CUSHING'S SYNDROME AND PRIMARY ALDOSTERONISM*
Biglieri, E. G., Hane, S., Slaton, P. E., & Forsham, P. H. (1963) · Journal of Clinical Investigation · doi:10.1172/jci104740 · Cited by 112
Young, M. J., & Funder, J. W. (2004) · Endocrinology · doi:10.1210/en.2004-0005 · Cited by 112
Padfield, P. L., Brown, J. J., Lever, A. F., Schalekamp, M. A. D. H., Beevers, D. G., Davies, D. L., Robertson, J. I. S., Tree, M., & Titterington, M. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91559-7 · Cited by 112
Vantrimpont, P. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1093 · Cited by 111
Takebayashi, K., Matsumoto, S., Aso, Y., & Inukai, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1718 · Cited by 110
Lim, P. O., MacDonald, T. M., Holloway, C., Friel, E. C., Anderson, N., Dow, E., Jung, R. T., Davies, E., Fraser, R., & Connell, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-012070 · Cited by 109
Self-citationAdrenocortical zonation and ACTH
Vinson, G. P. (2003) · Microscopy Research and Technique · doi:10.1002/jemt.10331 · Cited by 109
Genetic Determinants of Hypertension: Identification of Candidate Phenotypes
Kotchen, T. A., Kotchen, J. M., Grim, C. E., George, V. T., Kaldunski, M. L., Cowley, A. W., Hamet, P., & Chelius, T. H. (2000) · Hypertension · doi:10.1161/01.hyp.36.1.7 · Cited by 109
Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ
Bhalla, V., Soundararajan, R., Pao, A. C., Li, H., & Pearce, D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00061.2006 · Cited by 103
Kraus*, D., Jäger*, J., Meier, B., Fasshauer, M., & Klein, J. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870240 · Cited by 102
Adiponectin and Insulin Sensitivity in Primary Aldosteronism
FALLO, F., DELLAMEA, P., SONINO, N., BERTELLO, C., ERMANI, M., VETTOR, R., VEGLIO, F., & MULATERO, P. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.03.012 · Cited by 101
Hood, S. J., Taylor, K. P., Ashby, M. J., & Brown, M. J. (2007) · Circulation · doi:10.1161/circulationaha.107.690396 · Cited by 101
Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males
HAUTANEN, A., HAUTANEN, A., LANKINEN, L., KUPARI, M., JÄNNE, O. A., ADLERCREUTZ, H., NIKKILÄ, H., & WHITE, P. C. (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00308.x · Cited by 101
Sugiyama, T., Yoshimoto, T., Tsuchiya, K., Gochou, N., Hirono, Y., Tateno, T., Fukai, N., Shichiri, M., & Hirata, Y. (2005) · Endocrinology · doi:10.1210/en.2004-1674 · Cited by 100
Aldosterone: Direct Effects on and Production by the Heart
White, P. C. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030373 · Cited by 97
The 3β-hydroxysteroid dehydrogenase gene family of enzymes
Mason, J. I. (1993) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(93)90117-w · Cited by 95
Lys 173 Arg and −344T/C Variants of CYP11B2 in Japanese Patients With Low-Renin Hypertension
Komiya, I., Yamada, T., Takara, M., Asawa, T., Shimabukuro, M., Nishimori, T., & Takasu, N. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.699 · Cited by 95
Coll, A. P., Challis, B. G., Yeo, G. S. H., Snell, K., Piper, S. J., Halsall, D., Thresher, R. R., & O’Rahilly, S. (2004) · Endocrinology · doi:10.1210/en.2004-0491 · Cited by 93
Cautions over the current epidemic of primary aldosteronism
Kaplan, N. M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04223-9 · Cited by 92
KEM, D. C., GOMEZ-SANCHEZ, C., KRAMER, N. J., HOLLAND, O. B., & HIGGINS, J. R. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-1-116 · Cited by 90
Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects
Daidoh, H., Morita, H., Mune, T., Murayama, M., Hanafusa, J., NI, H., Shibata, H., & Yasuda, K. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02037.x · Cited by 89
Cicoira, M., Zanolla, L., Franceschini, L., Rossi, A., Golia, G., Zeni, P., Caruso, B., & Zardini, P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02261-5 · Cited by 88
Simard, J., Couet, J., Durocher, F., Labrie, Y., Sanchez, R., Breton, N., Turgeon, C., & Labrie, F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36567-6 · Cited by 87
Lin, L., Hindmarsh, P. C., Metherell, L. A., Alzyoud, M., Al‐Ali, M., Brain, C. E., Clark, A. J. L., Dattani, M. T., & Achermann, J. C. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02709.x · Cited by 87
FXYD Proteins: New Tissue‐ and Isoform‐Specific Regulators of Na,K‐ATPase
GEERING, K., BÉGUIN, P., GARTY, H., KARLISH, S., FÜZESI, M., HORISBERGER, J., & CRAMBERT, G. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07219.x · Cited by 87
Sookoian, S., Gianotti, T. F., González, C. D., & Pirola, C. J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000254372.88488.a9 · Cited by 86
Clinical and Genetic Correlates of Serum Aldosterone in the Community: The Framingham Heart Study
KATHIRESAN, S., LARSON, M., BENJAMIN, E., COREY, D., MURABITO, J., FOX, C., WILSON, P., RIFAI, N., MEIGS, J., & RICKEN, G. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.12.005 · Cited by 86
McALLISTER, J. M., & HORNSBY, P. J. (1988) · Endocrinology · doi:10.1210/endo-122-5-2012 · Cited by 84
Tsujita, Y., Iwai, N., Katsuya, T., Higaki, J., Ogihara, T., Tamaki, S., Kinoshita, M., Mannami, T., Ogata, J., & Baba, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.105 · Cited by 84
Weidmann, P. U., de Châtel, R., Schiffmann, A., Bachmann, E., Beretta-Piccoli, C., Reubi, F., Ziegler, W. H., & Vetter, W. (1977) · Journal of Molecular Medicine · doi:10.1007/bf01476959 · Cited by 83
A hybrid cell mapping panel for regional localization of probes to human chromosome 8
Wagner, M. J., Ge, Y., Siciliano, M., & Wells, D. E. (1991) · Genomics · doi:10.1016/0888-7543(91)90491-v · Cited by 83
Mineralocorticoid receptor binding, structure and function
Rogerson, F. M., Brennan, F. E., & Fuller, P. J. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.021 · Cited by 83
TUCCI, J. R., ESPINER, E. A., JAGGER, P. I., PAUK, G. L., & LAULER, D. P. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-4-568 · Cited by 82
Aldosterone Is Produced From Ventricles in Patients With Essential Hypertension
Yamamoto, N., Yasue, H., Mizuno, Y., Yoshimura, M., Fujii, H., Nakayama, M., Harada, E., Nakamura, S., Ito, T., & Ogawa, H. (2002) · Hypertension · doi:10.1161/01.hyp.0000015905.27598.e9 · Cited by 81
Young, M. J., & Funder, J. W. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00270-8 · Cited by 81
Athyros, V. G., Mikhailidis, D. P., Kakafika, A. I., Τζιόμαλος, Κ., & Karagiannis, A. I. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.5.529 · Cited by 80
Genetic variation in P450c11AS in Chilean patients with low renin hypertension
Fardella, C. E., Rodriguez, H., Montero, J., Zhang, G., Vignolo, P., Rojas, A., Villarroel, L., & Miller, W. L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954040 · Cited by 77
Denner, K., Doehmer, J., & Bernhardt, R. (1995) · Endocrine Research · doi:10.3109/07435809509030460 · Cited by 77
Salt, sodium channels, and SGK1
Pearce, D., & Kleyman, T. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31538 · Cited by 74
Ye, P., Kenyon, C. J., MacKenzie, S. M., Seckl, J. R., Fraser, R., Connell, J. M. C., & Davies, E. (2003) · Endocrinology · doi:10.1210/en.2003-0109 · Cited by 74
Self-citationInglis, G. C., Ingram, M. C., Holloway, C. D., Swan, L., Birnie, D., Hillis, W. S., Davies, E., Fraser, R., & Connell, J. M. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6146 · Cited by 74
Self-citationHr, B., Sealey, J. E., & Jh, L. (1973) · PubMed · Cited by 74
Bird, I. M. (1994) · Endocrinology · doi:10.1210/en.134.6.2468 · Cited by 73
Hollenberg, N. K., Williams, G., Burger, B., & Hooshmand, I. (1975) · Clinical Science · doi:10.1042/cs0490527 · Cited by 73
Assignment of the human 3β-hydroxysteroid dehydrogenase gene (HSDB3) to the p13 band of chromosome 1
Bérubé, D., Luu The, V., Lachance, Y., Gagné, R., & Labrie, F. (2008) · Cytogenetics and Cell Genetics · doi:10.1159/000132878 · Cited by 71
Bird, I. M. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.6.2171 · Cited by 70
Partial deficiency of adrenal 11-hydroxylase. A possible cause of primary hypertension.
SIMONE, G. D., Tommaselli, A. P., Rossi, R., Valentino, R., Lauria, R., Scopacasa, F., & Lombardi, G. (1985) · Hypertension · doi:10.1161/01.hyp.7.2.204 · Cited by 67
The Evolution of Mineralocorticoid Receptors
Hu, X., & Funder, J. W. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0247 · Cited by 66
Zhou, X., Ono, H., Ono, Y., & Frohlich, E. D. (2004) · American Journal of Nephrology · doi:10.1159/000077396 · Cited by 66
Shinzawa, K., Ishibashi, S., Murakoshi, M., Watanabe, K., Kominami, S., Kawahara, A., & Takemori, S. (1988) · Journal of Endocrinology · doi:10.1677/joe.0.1190191 · Cited by 66
Makhanova, N., Sequeira-Lόpez, M. L. S., Gómez, R. A., Kim, H., & Smithies, O. (2006) · Hypertension · doi:10.1161/01.hyp.0000249902.09036.e7 · Cited by 65
Corticosteroid synthesis in the central nervous system
Gomez-sanchez, C. E., Zhou, M. Y., Cozza, E. N., Morita, H., Eddleman, F. C., & Gomez-sanchez, E. P. (1996) · Endocrine Research · doi:10.1080/07435809609043732 · Cited by 64
Mellon, S. H., Bair, S. R., & Monis, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.4.1643 · Cited by 63
Treatment of Hypertension With Spironolactone: Double-Blind Study
Rl, W. (1966) · JAMA · doi:10.1001/jama.198.11.1143 · Cited by 63
Glomerulosa cell—a unique sensor of extracellular K+ concentration
Spät, A. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.046 · Cited by 62
Holland, O. B. (1993) · Endocrinology · doi:10.1210/en.132.6.2666 · Cited by 62
Inglis, G. C. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4132 · Cited by 62
Sanz‐Rosa, D., Cediel, E., Heras, N. D. L., Miana, M., Balfagón, G., Lahera, V., & Cachofeiro, V. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000170379.08214.5a · Cited by 61
Reflections on sterol sidechain cleavage process catalyzed by cytochrome P450scc
Lieberman, S., & Lin, Y. Y. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00068-1 · Cited by 60
Fardella, C. E., Hum, D. W., Rodriguez, H., Zhang, G., Barry, F. L., Ilicki, A., Bloch, C. A., & Miller, W. L. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550772 · Cited by 60
Tait, S. A. S., Tait, J. F., & Coghlan, J. P. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.004 · Cited by 59
Investigation of aldosterone-synthase inhibition in rats
Ménard, J., Gonzalez, M.-F., Guyene, T.-T., & Bissery, A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226205.65442.f2 · Cited by 57
Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues
Sharma, K. K., Lindqvist, A., Zhou, X. J., Auchus, R. J., Penning, T. M., & Andersson, S. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.024 · Cited by 57
Ye, P., Kenyon, C. J., MacKenzie, S. M., de Jong, A. S., Miller, C., Gray, G. A., Wallace, A., Ryding, A. S., Mullins, J. J., McBride, M., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0370 · Cited by 55
Self-citation
Cited by
Vitamin D status and arterial hypertension: a systematic review
Pilz, S., Tomaschitz, A., Ritz, E., & Pieber, T. R. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.135 · Cited by 406
“Mechanistic links with blood pressure The renin–angiotensin–aldosterone system Increased activation of the renin–angiotensin–aldosterone system (RAAS), which is a main regulator of electrolyte and volume homeostasis, contributes to the development of arterial hypertension”
BackgroundUpdate on tissue renin–angiotensin systems
Bader, M., & Ganten, D. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0336-0 · Cited by 293
“Mineralocorticoid receptor antagonists turned out to decrease the risk after myocardial infarction [59, 60 ].”
BackgroundParthasarathy, H. K., Ménard, J., White, W. B., Young, W. F., Williams, G. H., Williams, B., Ruilope, L. M., McInnes, G. T., Connell, J. M., & MacDonald, T. M. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283455ca5 · Cited by 281
Self-citationBlood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis
Burgaz, A., Orsini, N., Larsson, S. C., & Wolk, A. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834320f9 · Cited by 247
Amar, L., Azizi, M., Menard, J., Peyrard, S., Watson, C., & Plouin, P.-F. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157271 · Cited by 202
Metadata
- Authors
- Connell, J. M. C., MacKenzie, S. M., Freel, E. M., Fraser, R., & Davies, E.
- Affiliations
- British Heart Foundation (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-02-21
- Volume
- 29
- Issue
- 2
- Pages
- 133-154
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1977973738
- Semantic Scholar
- a5e9ead66dd474017e77ece0053f5ef285c2b773
- Cited by
- 182
- References
- 249
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 10 · 2023: 7 · 2022: 4 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 10 · 2016: 13 · 2015: 5 · 2014: 13 · 2013: 11 · 2012: 20
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- British Heart Foundation
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- aldosterone excess, essential hypertension, mineralocorticoid receptor, cardiovascular risk, aldosterone synthase, CYP11B2, CYP11B1, 11β-hydroxylase, ischemic heart disease, proinflammatory molecules, reactive oxygen species, genetic and environmental factors, spironolactone, eplerenone, mineralocorticoid receptor antagonists, myocardial infarction
- MeSH terms
- Aldosterone, Animals, Cardiovascular Physiological Phenomena, Humans, Hyperaldosteronism, Hypertension, Renal, Renin-Angiotensin System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.